Search for: "Pfizer Inc. et al v. Watson Pharmaceuticals Inc. et al"
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
2 May 2010, 9:52 pm
Pfizer Inc. et al. v. [read post]
9 Oct 2011, 9:37 pm
Pfizer Inc. et al. v. [read post]
10 Mar 2013, 9:59 pm
Searle LLC et al. v. [read post]
18 Dec 2009, 9:59 am
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
9 Oct 2009, 9:11 am
PLIVA-HRVATSKA d.o.o, PLIVA d.d., Barr Laboratories Inc., Barr Pharmaceuticals Inc., Barr Pharmaceuticals, LLC, et al. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/15: Pfizer Inc., Pharmacia Corp., Pharmacia & Upjohn Co., Pharmacia & Upjohn LLC, Pharmacia & Upjohn Company LLC, et al. v. [read post]
5 May 2010, 4:46 am
Watson Pharmaceuticals, Inc. et al. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc.; Abbott Laboratories et al. v. [read post]
15 Jun 2011, 4:56 am
Watson Pharmaceuticals, Inc. et al. [read post]
9 Dec 2009, 3:59 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
6 Apr 2011, 12:18 am
Patent and Trademark Office, et. al. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
